Monday - September 23
Monday - September 23
| 15:40 - 16:40 | Thematic Session: Genetics in precision medicine |
|
Genetics for precision medicine in transplantation Shane T Grey, Australia |
|
Biopsy transcriptomics for diagnosis and research Jasper Callemeyn, Belgium |
|
Identifying operational tolerance Sophie Brouard, France |
| 15:40 - 16:40 | Thematic Session: Promises of big data and AI - facts or fiction? |
|
Machine learning model for outcome prediction Nancy Kwan Man, Hong Kong |
|
Application of AI in transplant pathology Weijia Zhang, United States |
|
Developing transplant registries in LMIC and MIC Adisorn Lumpaopong, Thailand |
| 15:40 - 16:40 | Thematic Session: Uterus-transplantation: Where are we now |
|
10 years after the first successful uterus transplant: How will the
teenage years look? Mats Brannstrom, Sweden |
|
Ethical guardrails in uterus transplantation Anji Wall, United States |
|
Uterus-specific aspects of alloimmunity and immunosuppression Paige Porrett, United States |
| 15:40 - 16:40 | Thematic Session: Clinical trials design and end-points in transplantation |
|
Innovative trial design in transplantation Andrea Viecelli, Australia |
|
The Parsons Model - ethical implications of research involving
those determined dead by neurological criteria Jayme Locke, United States |
|
Trials in immunosuppression/Long term in kidney transplantation Roslyn B. Mannon, United States |
| 15:40 - 16:40 | Thematic Session: Organ utilization - do we need to challenge each other to do better? |
|
The promise of equity in a deceased donor allocation system Chris Callaghan, United Kingdom |
|
Strategies to improve non-utilisation rates of deceased donors Sumit Mohan, United States |
|
Reducing the risk of donor transmitted disease Beatriz Dominguez-Gil, Spain |
| 15:40 - 16:40 | Thematic Session: Life participation and living well after transplantation |
|
Living well after transplantation Bill Wang, Hong Kong |
|
Work, life, and sex after transplantation Louise Lerminiaux, Costa Rica |
|
Prehabilitation into transplant and beyond Marieke Vandecruys, Belgium |
| 15:40 - 16:40 | Thematic Session: Pancreas and islet |
|
Beta cell replacement (whole pancreas, islet and cell
transplantation) within the treatment landscape of type 1
diabetes Braulio Alejandro Marfil-Garza, Mexico |
|
Deciphering the immunological enigma of allo-beta cell
transplantation: Addressing unresolved questions and embracing the
frontiers of knowledge Lorenzo Piemonti, Italy |
Tuesday - September 24
Tuesday - September 24
| 15:40 - 16:40 | Thematic Session: Advances in antibody assessment |
|
ABO antibodies - future perspectives Lori J. West, Canada |
|
Advances in AB detection: From Luminex to Eplets and more Cynthia Kramer, Netherlands |
| 15:40 - 16:40 | Thematic Session: Equity and access to transplantation |
|
Risks to equity in organ allocation introduced by AI Mamatha Bhat, Canada |
|
Disparity in access to solid organ transplantation Lungiswa Mtingi-Nkonzombi, South Africa |
|
Sex and gender disparities in transplantation access Bethany Foster, Canada |
| 15:40 - 16:40 | Thematic Session: Reproductive care - General |
|
Gestational outcomes for transplant recipients: A focus on fetal
health Margriet FC de Jong, Netherlands |
|
Impact of pregnancy on graft function in kidney Tx Marleen van Buren, Netherlands |
|
Reproductive planning - why & how Shilpanjali Jesudason, Australia |
| 15:40 - 16:40 | Thematic Session: Cellular therapies |
|
Dendritic cells - insights from clinical trials Angus W Thomson, United States |
|
CAR-Treg optimization Mohsen Khosravi-Maharlooei, United States |
|
Adoptive t-cell therapy for infections Patrizia Comoli, Italy |
| 15:40 - 16:40 | Thematic Session: Organ perfusion and preservation |
|
Novel delivery of cellular therapy to reduce ischemia reperfusion
injury in kidney transplantation Emily R. Thompson, United Kingdom |
|
Ex-situ machine perfusion (heart, liver, kidney) (standard,
oxygenated, hypothermic, normothermic) Gabriel Oniscu, Sweden |
|
Cryopreservation Erik Finger, United States |
| 15:40 - 16:40 | Thematic Session: Dealing with post-transplant complications |
|
De novo malignancy post-transplant Naoka Murakami, United States |
|
What's new in vaccines? Andrew Karaba, United States |
|
Managing post-transplant metabolic disease Wai Lim, Australia |
| 15:40 - 16:40 | Thematic Session: Kidney transplant surgery |
|
The best way to procure live donor kidneys: Robotic vs.
laparoscopic donor nephrectomy Chandra Bhati, United States |
|
Robotic renal transplantation: State of the art Sangil Min, Korea |
|
Robotic renal transplantation: A niche approach for selected
patients or the future surgical approach for all? Timucin Taner, United States |
Wednesday, September 25
Wednesday, September 25
| 15:25 - 16:25 | Thematic Session: Surfing the big data wave |
|
Patient centred outcomes measures Nicole J Scholes-Robertson, Australia |
|
Genomics strategies to redefine histocompatibility and risk
stratification Sophie Limou, France |
|
Is AI better than human in predicting post-transplant outcomes? Carmen Lefaucheur, France |
| 15:25 - 16:25 | Thematic Session: Regenerative medicine |
|
Regenerative medicine in cardiology James Chong, Australia |
|
Overcoming senescence to improve transplant outcome Anette Melk, Germany |
| 15:25 - 16:25 | Thematic Session: Patient-centered care |
|
Ready-Steady-Go/A blueprint for health care transition in
Europe? Arvind Nagra, United Kingdom |
|
The therapy in wellness, movement and community Liz Schick, United Kingdom |
| 15:25 - 16:25 | Thematic Session: Normothermic regional perfusion (A-NRP and TA-NRP) |
|
Implications of NRP and especially TA-NRP for death
determination Dale Gardiner, United Kingdom |
|
|
The surgical approach - the US perspective Anji Wall, United States |
|
The surgical approach - the Spanish perspective Alicia Pérez, Spain |
| 15:25 - 16:25 | Thematic Session: Infection complications in transplantation |
1
|
Climate change and Infection - how it affects transplantation Ilan Schwartz, United States |
2
|
COVID-19 infections and impact on transplant outcomes in the
Middle-East Sibel G. Gocay Bek, Turkey |
3
|
Recurrent UTI in solid organ transplant recipient Deepali Kumar, Canada |
| 15:25 - 16:25 | Thematic Session: Minimally invasive recipient surgery: The future is here (Liver) |
|
How far can we expand the indication of Robot-assisted LDLT? Dieter C. Broering, Saudi Arabia |
|
Which is better for graft extraction/insertion? Upper midline
incision vs, Pfannenstiel incision Mohamed Rela, India |
|
Which is better for graft explant and/or graft implantation?
Laparoscopic vs. Robot Assisted Kwang-Woong Lee, Korea |
| 15:25 - 16:25 | Thematic Session: Xenotransplantation’s regulatory road to the clinic |
|
History of Xenotransplantation and moving to clinical practice Wayne Hawthorne, Australia |
|
WHO leadership in developing global strategies for
xenotransplantation Efstratios (Stratos) Chatzixiros, Switzerland |
|
Moving forward to ensure continuing registration of clinical
Xenotransplantation Leo Hans Buhler, Switzerland |